Whether on the news or on Netflix, dystopia seems the theme of the year. With a disturbing score from Max Richter, Wayne McGregor’s enthralling and infuriating interpretation of Margaret Atwood’s ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

As we previously reported, this August the European Commission granted approval for Celltrion’s STELARA biosimilar, STEQEYMA. Earlier this ...

Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio.

Reversing an earlier decision, European regulators recommended that the Alzheimer’s therapy Leqembi should be approved ...

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Sales of sex stimulation and potency-enhancing drugs are witnessing a rapid rise in India, especially among the young ...

Tilray Medical launches its first German-grown cannabis products under a new cultivation license, tapping into Germany's ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

Currently, in Europe, the first of these two drugs ... The phosphodiesterase 5 inhibitor mirodenafil, a drug from the Viagra ...

During the third quarter, Annovis received $4.4 million in net cash from its April 2024 ELOC facility. As of November 8, 2024, a total of $12.7 million in net cash has been raised with the ELOC year ...